Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma.

Hematology (Amsterdam, Netherlands) - 1 Dec 2024

Tang Xiaoyan, Chen Yongping

Abstract excerpt

BACKGROUND: TP53 gene mutation is crucial in determining the prognosis of Multiple Myeloma (MM) patients. Understanding metabolic genes linked to TP53 mutation is vital for developing targeted therapies for these patients. METHOD: We analyzed The Cancer Genome Atlas (TCGA) dataset to identify genes related to TP53 mutation and metabolism. Using univariate Cox regression and protein-protein interaction (PPI)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Neoplastic
Share to Multiple Myeloma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Ribonucleoside Diphosphate Reductase

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39012217
DOI: 10.1080/16078454.2024.2377850

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma.PMID 39012217Read ↗

Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity.Semantic proximity Read ↗

Mitophagy-related gene signature for predicting the prognosis of multiple myelomaSemantic proximity Read ↗

Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor ResistanceSemantic proximity Read ↗

Prognostic value of fatty acid metabolism-related signature and integrated analysis of the immune microenvironment in multiple myelomaSemantic proximity Read ↗

Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myelomaSemantic proximity Read ↗

Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myelomaSemantic proximity Read ↗

A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity Read ↗

Metabolic Effects of Recurrent Genetic Aberrations in Multiple MyelomaSemantic proximity Read ↗

Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.Semantic proximity Read ↗

Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple MyelomaSemantic proximity Read ↗

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaSemantic proximity Read ↗

Unveiling the cholesterol metabolism-Multiple Myeloma Linkage: Insights from Integrative Analysis of GEO and COMPASS-MMRF databases and Mendelian RandomizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.